1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
